Need all Congresses? Press Enter for expanded federal results.

SB 3221

Illinois Senate bill in Session 104.

Status: in_committee. Latest action: February 2, 2026.

CONTROLLED SUB-XYLAZINE.

Bill ID IL-104-SB-3221
Session 104
Status in_committee
Committee Assignments
Senate in_committee 2026-02-02
Summary

Amends the Illinois Controlled Substances Act. Makes structural and other changes to the list of controlled substances. Adds xylazine as a Class III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian. Defines "isomer"". Effective January 1, 2027."

Sponsor
Julie A. Morrison
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-02-02 Introduced Bill introduced
2026-02-02 Status in_committee
2026-02-02 Latest Action 2/02/2026 - Senate:
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States